AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 8

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.31 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020484LiraglutideKPKP-2502-E5631Janoshik2025-Q199.626.6898.1Supplier-supplied0PASS
AX-2025-020008RetatrutideSWBSWB-2411-R7167Janoshik2025-Q198.344.2398.1Buyer-sourced0PASS
AX-2025-019609GHRP-2TFCTFC-2411-A2083Janoshik2025-Q199.792.07—Buyer-sourced0PASS
AX-2025-019058MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783Janoshik2025-Q199.626.26105.6Laboratory-retained0FAIL
AX-2025-018640TirzepatideQSCQSC-2408-T5296Kestrel2025-Q199.935.3989.9Buyer-sourced1MARGINAL
AX-2025-020822ThymalinCPCCPC-2501-V2021Janoshik2025-Q1N/A6.68—Supplier-supplied1N/A
AX-2025-019804L-Glutathione (reduced)HomopeptideHOMO-2501-D4371PeptideMeter2025-Q199.298.52101.5Buyer-sourced0PASS
AX-2025-019061MK-677 (Ibutamoren mesylate)GSPGSP-2501-R2783Janoshik2025-Q199.495.70—Buyer-sourced0FAIL
AX-2025-019046N-Acetyl Semax AmideASYASY-{CAT}-2147Janoshik2025-Q199.888.52—Buyer-sourced0PASS
AX-2025-018956TirzepatideASYASY-{CAT}-1244VendorInvestigate2025-Q198.264.98101.8Buyer-sourced1FAIL
AX-2025-018850DihexaFGPFGP-2408-S8496Kestrel2025-Q199.697.3195.1Buyer-sourced0PASS
AX-2025-018723Kisspeptin-10QSCQSC-2412-W6783VendorInvestigate2025-Q199.935.7089.0Buyer-sourced1MARGINAL
AX-2025-018505SemaglutideWWBWWB-2501-K3141Janoshik2025-Q198.354.54105.7Buyer-sourced1MARGINAL
AX-2025-018444SemaglutideWWBWWB-2501-Y2776VendorInvestigate2025-Q198.753.9794.1Buyer-sourced0PASS
AX-2025-021146MOTS-cSIGSIG-2412-6332Medutest2025-Q198.843.81—Buyer-sourced0PASS
AX-2025-021042CJC-1295 (no DAC)BCHBCH-2502-A4465Janoshik2025-Q197.834.04—Buyer-sourced1FAIL
AX-2025-021025PT-141 (Bremelanotide)WXTWXT-2411-R3766Medutest2025-Q198.696.18—Buyer-sourced0PASS
AX-2025-020214SemaglutideGGPepsGGPE-2501-W1875Janoshik2025-Q198.675.59—Buyer-sourced0PASS
AX-2025-019670SurvodutideTFCTFC-2409-Y1996VendorInvestigate2025-Q199.276.12—Buyer-sourced0PASS
AX-2025-019666AfamelanotideTFCTFC-2502-Y2346Medutest2025-Q199.374.93—Buyer-sourced1MARGINAL
AX-2025-019653GHRP-2TFCTFC-2502-D2333Janoshik2025-Q199.875.35—Buyer-sourced0PASS
AX-2025-019533IpamorelinTFCTFC-2408-T9161PeptideMeter2025-Q198.944.01—Buyer-sourced0FAIL
AX-2025-019531IpamorelinTFCTFC-2408-T9161Janoshik2025-Q198.993.7396.1Buyer-sourced0FAIL
AX-2025-019375GHRP-2HYBHYB-2501-R7240Janoshik2025-Q199.804.76—Buyer-sourced0PASS
AX-2025-018960TirzepatideASYASY-{CAT}-1489Janoshik2025-Q198.467.32—Buyer-sourced0PASS
AX-2025-018847DihexaFGPFGP-2408-S8496Nordanalyt2025-Q199.656.46—Buyer-sourced0PASS
AX-2025-018837CJC-1295 (no DAC)FGPFGP-2503-P8516Janoshik2025-Q199.126.3795.1Buyer-sourced0PASS
AX-2025-018666TirzepatideQSCQSC-2410-R5814Medutest2025-Q199.935.25—Buyer-sourced0PASS
AX-2025-020823ThymalinCPCCPC-2501-V2021Janoshik2025-Q1N/A6.16—Buyer-sourced1N/A
AX-2025-020637TirzepatideGL BiochemGLBI-2412-R8446PeptideMeter2025-Q198.954.6389.9Buyer-sourced2FAIL
AX-2025-020499SermorelinKPKP-2501-V5712PeptideMeter2025-Q198.355.76—Buyer-sourced1MARGINAL
AX-2025-020015AOD-9604SWBSWB-2502-N7040Janoshik2025-Q199.355.10106.7Buyer-sourced0PASS
AX-2025-019928TirzepatideHJHJ-2502-P6662Janoshik2025-Q199.592.45104.1Buyer-sourced0PASS
AX-2025-019780RetatrutideHomopeptideHOMO-2409-R4202Janoshik2025-Q199.603.51102.8Buyer-sourced0PASS
AX-2025-019761SemaglutideHomopeptideHOMO-2501-D4523Janoshik2025-Q199.335.8990.9Buyer-sourced0PASS
AX-2025-018762BPC-157QSCQSC-2412-D7527Janoshik2025-Q199.415.5590.7Buyer-sourced0PASS
AX-2025-018750CJC-1295 (no DAC)QSCQSC-2411-D7855VendorInvestigate2025-Q199.023.81—Buyer-sourced0PASS
AX-2025-020687SelankSGNSGN-2409-H8807Medutest2025-Q198.336.2891.6Buyer-sourced0FAIL
AX-2025-020684SelankSGNSGN-2409-H8807Janoshik2025-Q198.286.60105.5Laboratory-retained0FAIL
AX-2025-020018AOD-9604SWBSWB-2502-N7040VendorInvestigate2025-Q199.414.63—Buyer-sourced0PASS